We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+17.84%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$6.62B
AUM Growth
+$1.04B
Cap. Flow
+$354M
Cap. Flow %
5.34%
Top 10 Hldgs %
56.45%
Holding
75
New
10
Increased
28
Reduced
21
Closed
9

Top Buys

Rank Stock Value
1
FLR icon
Fluor
FLR
+$160M
2
VTRS icon
Viatris
VTRS
+$101M
3
FTAI icon
FTAI Aviation
FTAI
+$83.8M
4
VST icon
Vistra
VST
+$70.9M
5
PCG icon
PG&E
PCG
+$58.6M

Top Sells

Rank Stock Value
1
TLN
Talen Energy Corp
TLN
+$384M
2
COOP
Mr. Cooper
COOP
+$74.8M
3
FLG
Flagstar Bank National Association
FLG
+$74.7M
4
ADPT icon
Adaptive Biotechnologies
ADPT
+$62.3M
5
DOLE icon
Dole
DOLE
+$60M

Sector Composition

Rank Sector Weight
1 Healthcare 32.2%
2 Utilities 29.09%
3 Industrials 10.97%
4 Energy 7.79%
5 Financials 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSAT icon
51
Telesat
TSAT
$916M
$20.6M 0.31%
843,781
-15,731
-2% -$276K
CEG icon
52
Constellation Energy
CEG
$98.9B
$17.6M 0.27%
+54,507
New +$14.4M
SCPH
53
DELISTED
scPharmaceuticals
SCPH
$17.5M 0.26%
4,601,977
-173,023
-4% -$537K
ZVRA icon
54
Zevra Therapeutics
ZVRA
$678M
$17.3M 0.26%
1,958,318
+740,584
+61% +$6.01M
CXW icon
55
CoreCivic
CXW
$3.3B
$17.2M 0.26%
815,280
+421,391
+107% +$9.09M
ANIP icon
56
ANI Pharmaceuticals
ANIP
$1.71B
$16.8M 0.25%
257,669
+200,998
+355% +$13.1M
TH icon
57
Target Hospitality
TH
$1.65B
$15.6M 0.24%
2,189,456
+189,456
+9% +$1.32M
SEG
58
Seaport Entertainment Group
SEG
$375M
$10.6M 0.16%
568,530
-4,878
-0.9% -$93.6K
EMBC icon
59
Embecta
EMBC
$269M
$10.1M 0.15%
1,037,416
-50,238
-5% -$565K
ABUS icon
60
Arbutus Biopharma
ABUS
$899M
$4.87M 0.07%
1,575,376
-105,714
-6% -$351K
MYPS icon
61
PLAYSTUDIOS Inc
MYPS
$77.9M
$3.53M 0.05%
2,697,384
-13,806
-0.5% -$19K
EDSA icon
62
Edesa Biotech
EDSA
$51.8M
$1.4M 0.02%
687,500
– –
TXMD icon
63
TherapeuticsMD
TXMD
$24M
$1.38M 0.02%
1,192,191
– –
CHRS icon
64
Coherus Oncology
CHRS
$184M
$635K 0.01%
867,800
-4,390,954
-83% -$3.79M
OVID icon
65
Ovid Therapeutics
OVID
$495M
$158K ﹤0.01%
478,533
-4,837,436
-91% -$1.46M
DOLE icon
66
Dole
DOLE
$1.23B
– –
-4,155,656
Closed -$60M
HOWL icon
67
Werewolf Therapeutics
HOWL
$18.6M
– –
-1,333,893
Closed -$1.3M
MD icon
68
Pediatrix Medical
MD
$2.14B
– –
-3,133,299
Closed -$45.4M
OABI icon
69
OmniAb
OABI
$500M
– –
-2,850,588
Closed -$6.84M
PLAB icon
70
Photronics
PLAB
$1.96B
– –
-1,862,737
Closed -$38.7M
SIMO icon
71
Silicon Motion
SIMO
$8.29B
– –
-700,882
Closed -$35.4M
WBA
72
DELISTED
Walgreens Boots Alliance
WBA
– –
-5,007,592
Closed -$55.9M
FLG
73
Flagstar Bank National Association
FLG
$5.9B
– –
-6,425,000
Closed -$74.7M
FNA
74
DELISTED
Paragon 28, Inc.
FNA
– –
-1,879,635
Closed -$24.5M
1 2
3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q2 2025 Portfolio in Review

As of Q2 2025, Rubric Capital Management (New York) held 75 positions worth $6.62B, up 19% from $5.58B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Rubric Capital Management (New York) deployed $354M of net new capital in Q2 2025, opening 10 new positions and adding to 28 existing holdings. Its largest new stake was Fluor: 4,000,000 shares worth $205M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 37% a quarter earlier, followed by Utilities and Industrials.

On the sell side, the largest reduction was Talen Energy Corp, an estimated $384M trimmed.

  • Rubric Capital Management (New York)'s largest Q2 2025 buy was Fluor: 4,000,000 shares worth $205M.
  • Rubric Capital Management (New York) added most to FTAI Aviation in Q2 2025, an estimated $83.8M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2025 reduction was Talen Energy Corp, cutting an estimated $384M.
  • Rubric Capital Management (New York) fully exited Flagstar Bank National Association in Q2 2025, selling an estimated $74.7M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 56% of its $6.62B portfolio in Q2 2025.
  • Rubric Capital Management (New York) opened 10 new positions and closed 9 in Q2 2025.
  • Rubric Capital Management (New York)'s portfolio value rose 19% quarter-over-quarter to $6.62B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2025, filed 14 Aug 2025.